CD4+ T-cell restoration after 48 weeks in the maraviroc treatment-experienced trials MOTIVATE 1 and 2
Published inJournal of acquired immune deficiency syndromes, vol. 54, no. 4, p. 394-397
Publication date2010
Abstract
Keywords
- CD4 Lymphocyte Count
- CD4-Positive T-Lymphocytes/drug effects/immunology
- Clinical Trials as Topic
- Cyclohexanes/adverse effects/*therapeutic use
- Drug Resistance, Viral
- HIV Fusion Inhibitors/adverse effects/*therapeutic use
- Humans
- Opportunistic Infections/epidemiology
- T-Lymphocytes/drug effects/virology
- Time Factors
- Treatment Outcome
- Triazoles/adverse effects/*therapeutic use
Affiliation
Research group
Citation (ISO format)
ASMUTH, David M. et al. CD4+ T-cell restoration after 48 weeks in the maraviroc treatment-experienced trials MOTIVATE 1 and 2. In: Journal of acquired immune deficiency syndromes, 2010, vol. 54, n° 4, p. 394–397. doi: 10.1097/QAI.0b013e3181c5c83b
Main files (1)
Article
![accessLevelRestricted](assets/images/access-level-restricted.png)
Identifiers
- PID : unige:20748
- DOI : 10.1097/QAI.0b013e3181c5c83b
- PMID : 20009949
ISSN of the journal1525-4135